Published in Blut on March 01, 1972
Alterations of uromodulin biology: a common denominator of the genetically heterogeneous FJHN/MCKD syndrome. Kidney Int (2006) 1.65
Mobilization of iron from reticulocytes. Identification of pyridoxal isonicotinoyl hydrazone as a new iron chelating agent. FEBS Lett (1979) 0.98
Lymphatic metastases of bone tumors. Lymphology (1971) 0.96
Study of intracellular iron distribution in rabbit reticulocytes with normal and inhibited heme synthesis. Biochim Biophys Acta (1973) 0.93
Clinical and molecular characterization of a family with a dominant renin gene mutation and response to treatment with fludrocortisone. Clin Nephrol (2010) 0.91
The effect of inhibitors of energy metabolism on erythropoietin production. J Lab Clin Med (1972) 0.89
A study of intracellular iron metabolism using pyridoxal isonicotinoyl hydrazone and other synthetic chelating agents. Biochim Biophys Acta (1979) 0.88
Accumulation of heme in mitochondria from rabbit reticulocytes with inhibited globin synthesis. Biochim Biophys Acta (1973) 0.88
Cardioprotective effects of N-acetylcysteine: the reduction in the extent of infarction and occurrence of reperfusion arrhythmias in the dog. Int J Cardiol (1990) 0.87
Regulation of iron entry into reticulocytes. I. Feedback inhibitory effect of heme on iron entry into reticulocytes and on heme synthesis. Blood (1969) 0.86
Lymphatic system and organ transplantation. Lymphology (1968) 0.85
Lymphatic aspects of experimental and clinical renal transplantation. Bull Soc Int Chir (1970) 0.85
Evidence for the presence of free and protein-bound nonhemoglobin heme in rabbit reticulocytes. Biochim Biophys Acta (1972) 0.84
Changes in the protein content of plasma during blood losses in rats. Physiol Bohemoslov (1966) 0.84
The biological environment of Hodgkin's lymphoma and the role of the chemokine CCL17/TARC. Prague Med Rep (2009) 0.84
[Thromboembolic complications in patients undergoing in vitro fertilization: retrospective clinical study]. Ceska Gynekol (2004) 0.84
Changes in markers of anemia and iron metabolism and how they are influenced by antianemics in postpartum period. Acta Obstet Gynecol Scand (2001) 0.84
Feedback regulation by red cell mass of the sensitivity of the erythropoietin-producing organ to hypoxia. Blood (1970) 0.83
[Combined treatment of uterine myoma (uterine arteries embolization followed by laparoscopic myomectomy)]. Ceska Gynekol (2004) 0.83
Lymph and blood enzymes and pathologic alterations in canine experimental pancreatitis after administration of benzo-pyrones. Scand J Gastroenterol (1979) 0.83
Growth inhibition of an MC-induced mouse sarcoma by TCGF (IL 2)-containing preparations. Preliminary report. Cancer Immunol Immunother (1983) 0.83
Antilymphocyte serum and lymphatic system. I. The effect of regional administration on the survival of skin allografts. Transplantation (1969) 0.83
Cell death signalling pathways in the pathogenesis and therapy of haematologic malignancies: overview of apoptotic pathways. Folia Biol (Praha) (2006) 0.82
[Granulosa cell tumor--clinical group and literature review]. Ceska Gynekol (2000) 0.81
Prediction of insulin sensitivity in nonobese women with polycystic ovary syndrome. J Clin Endocrinol Metab (2002) 0.81
Effect of heme on globin messenger RNA synthesis in spleen erythroid cells. J Supramol Struct Cell Biochem (1981) 0.81
Detection of myocardial infarction by in vivo scanning. Cardiologia (1967) 0.81
Haem synthesis and iron uptake by reticulocytes. Br J Haematol (1974) 0.80
Cell death signalling pathways in the pathogenesis and therapy of haematologic malignancies: overview of therapeutic approaches. Folia Biol (Praha) (2006) 0.80
Effect of some cytostatics on the haemopoietic stem cells (CFUs) in blood. Cancer Chemother Pharmacol (1979) 0.80
Identification of leukemia cell-derived inhibitory activity (LIA) in conditioned media from human myeloid leukemic cell line ML-2. Blut (1986) 0.80
[Fetal fibronectin in cervico-vaginal secretions--an indicator of incipient premature labor using a membrane immunoassay]. Ceska Gynekol (1995) 0.79
The spectroscopy and photochemistry of naturally occurring and synthetic chromenes. Photochem Photobiol (1970) 0.79
Iron uptake from transferrin and transferrin endocytic cycle in Friend erythroleukemia cells. J Cell Physiol (1987) 0.79
Effect of polycythemia on erythropoietin production in the hypoxic rat. Am J Physiol (1972) 0.79
Non-transferrin donors of iron for heme synthesis in immature erythroid cells. Biochim Biophys Acta (1988) 0.78
[Changes in hemostasis and fibrinolysis in gestational diabetes]. Cas Lek Cesk (1996) 0.78
Transferrin and iron distribution in subcellular fractions of K562 cells in the early stages of transferrin endocytosis. Biochim Biophys Acta (1992) 0.78
The role of heme in the release of iron from transferrin in reticulocytes. Enzyme (1974) 0.78
The use of reticulocytes with high non-haem iron pool for studies of regulation of haem synthesis. Br J Haematol (1970) 0.78
[Sarcoma of the uterus]. Ceska Gynekol (1998) 0.78
[Complications of axillary dissection in breast carcinoma ]. Ceska Gynekol (2002) 0.78
[Effect of hormone replacement therapy on the cardiovascular system]. Ceska Gynekol (2002) 0.77
Control of iron delivery to haemoglobin in erythroid cells. Ciba Found Symp (1978) 0.77
[Effect of psychological factors on success of in vitro fertilization]. Ceska Gynekol (2001) 0.77
Regulation of iron entry into reticulocytes. II. Relationship between hemoglobin synthesis and entry of iron into reticulocytes. Biochim Biophys Acta (1971) 0.77
The use of exogenous -aminolaevulinic acid for the studies of the regulation of haem synthesis in rabbit reticulocytes. Biochim Biophys Acta (1973) 0.77
The distribution of major lymphocyte subsets in cord blood is associated with its pH. Clin Biochem (2001) 0.77
Proliferation rate of haemopoietic stem cells after damage by several cytostatic agents. Cell Tissue Kinet (1976) 0.77
The effect of plasma and transferrin on the hemin inhibition of iron uptake by reticulocytes. Experientia (1972) 0.77
[Laparoscopy in chronic pelvic pain--a retrospective clinical study]. Ceska Gynekol (2002) 0.77
[The 3mm optical system in hysteroscopy]. Ceska Gynekol (2002) 0.77
Biliary iron excretion in rats following pyridoxal isonicotinoyl hydrazone. Br J Haematol (1980) 0.77
Control of haemopoietic stem cell proliferation by cells in DNA synthesis. Br J Haematol (1976) 0.77
[Localization and uptake of chlortetracycline in the pancreas]. Cas Lek Cesk (1965) 0.77
The role of heme in the regulation of delta-aminolevulinic acid and heme synthesis in rabbit reticulocytes. Eur J Biochem (1969) 0.77
Inhibition of heme synthesis decreases transferrin receptor expression in mouse erythroleukemia cells. J Cell Physiol (1992) 0.76
[Hysteroscopic resection of submucosal myomas in abnormal uterine bleeding: results of a 4-year prospective study]. Ceska Gynekol (1999) 0.76
Effect of beta adrenergic blocking agents on erythropoiesis in rats. J Pharmacol Exp Ther (1983) 0.76
[Detection and occurrence of BRCA 1 gene mutation in patients with carcinoma of the breast and ovary]. Ceska Gynekol (2003) 0.76
[Characteristics of a population of drug dependent pregnant women in the Czech Republic]. Ceska Gynekol (2001) 0.76
[Effect of early onset of transdermal and oral estrogen therapy on the lipid profile: a prospective study with cross-over design]. Ceska Gynekol (2006) 0.75
[Velocity of the selective accumulation of Mercurascan 203 in injured muscle and in the ischemic myocardium]. Experientia (1967) 0.75
[Endotoxin shock and tetracycline antibiotics (author's transl)]. Cas Lek Cesk (1974) 0.75
[Distribution of antilymphocyte globulin and serum in the organism with special reference to the lymphatic system]. Cas Lek Cesk (1970) 0.75
[Changes of the lymph in experimental pancreatitis of the dog (author's transl)]. Cesk Gastroenterol Vyz (1977) 0.75
Vascular lesions in human allotransplantated kidneys. Virchows Arch A Pathol Pathol Anat (1970) 0.75
[Development of integration process in the Institute for Clinical and Experimental Medicine]. Cas Lek Cesk (1973) 0.75
[Osseous changes after kidney transplantation and their treatment]. Acta Chir Orthop Traumatol Cech (1974) 0.75
[Further advances in the topical diagnosis of ischemic myocardial lesions in vivo]. Cas Lek Cesk (1966) 0.75
[Current status and goals of organ transplantation in clinical medicine]. Cas Lek Cesk (1970) 0.75
[Tubular damage in allotransplanted human kidneys]. Zentralbl Allg Pathol (1972) 0.75
Tetracycline antibiotics in calciphylaxis. Chemotherapy (1967) 0.75
Experimental and clinical study with endotoxin shock. Int J Clin Pharmacol (1973) 0.75
[Therapy of experimental infection using gentamycin and carbenicillin during immunosuppression]. Rozhl Chir (1971) 0.75
[Contribution of lymphography to the early diagnosis of metastases in malignant tumors of extremities]. Acta Chir Orthop Traumatol Cech (1966) 0.75
[Significance of the lymphatic system for the transport of enzymes from the ischemic myocardium]. Cas Lek Cesk (1970) 0.75
Contribution to measurements of myocardial excitability. Cor Vasa (1971) 0.75
[Chemotherapy in immunosuppression and transplantation]. Cas Lek Cesk (1972) 0.75
[Aims and perspectives of the topical diagnosis of tissue damage]. Cas Lek Cesk (1966) 0.75
[New method of ureteroneocystostomy in transplantation of the kidneys]. Rozhl Chir (1974) 0.75
Histology and fine structure of necrotic renal allografts in man. J Pathol (1973) 0.75
The effect of Mercurascan on some enzymes of striated muscle in acute and chronic stages of ischaemia. Biochem Pharmacol (1978) 0.75
[Microbiological findings in patients with kidney transplantations]. Cas Lek Cesk (1970) 0.75
[Autotransplantation of a pancreas segment in the dog]. Rozhl Chir (1977) 0.75
[3-year clinical experience with renal allotransplantation]. Cas Lek Cesk (1970) 0.75
[Gentamicin in kidney transplantation]. Cas Lek Cesk (1970) 0.75
[Surgical complications following kidney transplantation]. Rozhl Chir (1977) 0.75
Studies on the therapeutic use of mercurascan (MSC). Part 1: Distribution of mercurascan in the body in experimental and clinical myocardial ischaemia. Int J Clin Pharmacol (1974) 0.75
Studies on the therapeutic use of mercurascan (MSC). Part 2: Antiarrhythmogenic and haemodynamic effect of MSC in experimental myocardial ischaemia. Int J Clin Pharmacol (1974) 0.75
The task of the transplantation centre of the Institute for Clinical and Experimental Medicine and the present state of the transplantation programme in the Czechoslovak Socialist Republic. Rev Czech Med (1973) 0.75
Renal ischaemia, hypoxia and erythropoietin production. Scand J Haematol (1972) 0.75
Renal rickets and kidney transplantation. A case report. Langenbecks Arch Chir (1974) 0.75
[The mercury radioisotope scanning test in myocardial ischemia induced by ligation of the coronary artery]. Cas Lek Cesk (1970) 0.75